As you could tell from my last post, I’ve really been focusing on the impact of any salvage treatment options on the quality of life (QOL), both during treatment and longer-term.
I stumbled across this 2008 study, Quality of Life and Satisfaction with Outcome among Prostate Cancer Survivors, published in the New England Journal of Medicine, but it shows the QOL impact after first-line treatment only.
Tables 2 and 4 in the paper are precisely how this data-driven, numbers geek would love to see the information on salvage therapies presented. Obviously, the categories measured may have to be modified and expanded to include the known side effects of the salvage treatments.
If Dr. Martin G. Sanda, et al., stumble across this post and care to build upon their previous excellent work, please feel free to do so! In the interim, I’ll keep searching.